SATPdb18674

A bioactive peptide.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
Supporting references
0
Contradictory references
0
AI-suggested references
0
Clinical trials

General information

SATPdb18674 annotated entry can be found here.

 

QYGSFCTQLNRALSGIAAEQ


Supporting references

Link Tested on Impact factor Notes Publication date
Targeting the GRP78-Dependant SARS-CoV-2 Cell Entry by Peptides and Small Molecules
Small molecule Peptide In silico
in silico 1.31

Predicted to bind the SARS-CoV-2 spike protein and glucose-regulating protein 78 receptor.

Oct/21/2020